KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Shares Outstanding (2016 - 2025)

Zoetis (ZTS) has disclosed Shares Outstanding for 13 consecutive years, with $501.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 11.91% to $501.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $501.9 million through Dec 2025, up 11.91% year-over-year, with the annual reading at $501.9 million for FY2025, 11.91% up from the prior year.
  • Shares Outstanding for Q4 2025 was $424.9 million at Zoetis, down from $501.9 million in the prior quarter.
  • The five-year high for Shares Outstanding was $501.9 million in Q2 2021, with the low at $424.9 million in Q4 2025.
  • Average Shares Outstanding over 5 years is $485.5 million, with a median of $501.9 million recorded in 2021.
  • Peak annual rise in Shares Outstanding hit 11.91% in 2025, while the deepest fall reached 11.55% in 2025.
  • Over 5 years, Shares Outstanding stood at $501.9 million in 2021, then changed by 0.0% to $501.9 million in 2022, then changed by 0.0% to $501.9 million in 2023, then dropped by 10.64% to $448.5 million in 2024, then rose by 11.91% to $501.9 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $501.9 million, $441.5 million, and $443.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.